Trial
NCT03594487
Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jeffrey Gelfand
Collaborators
—
Condition
Relapsing Remitting Multiple Sclerosis
Intervention
FMP30 Donor Stool
Why stopped
Under-enrollment, including after interruption due to a hold on source FMT material and the COVID-19 pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-03